Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saracatinib in Recurrent or Metastatic Soft Tissue Sarcoma
NCT00659360Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of saracatinib in soft tissue sarcoma (STS), sponsored by National Cancer Institute. Started Feb 2008; status: completed.
02
Drugs
saracatinib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00659360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659360.